latest news releases from the newsroom
Taking the Pain of Billing Out of House
PRINCETON, N.J., Feb. 6, 2007 (PRIME NEWSWIRE) -- Billtrust, the leading provider of outsource billing services, reports a significant increase in the number of companies outsourcing the billing function. They are also reporting triple-digit growth in the use of electronic billing delivery and payment programs.
Avigen Completes Safety, Tolerability and Pharmacokinetic Trial For AV411, a Potential First-in-Class Oral Treatment For Neuropathic Pain
ALAMEDA, Calif., Feb. 6, 2007 (PRIME NEWSWIRE) -- Avigen, Inc. (Nasdaq:AVGN) today announced findings from a safety and tolerability study with AV411 (ibudilast), an oral therapy intended for the treatment of neuropathic pain. Ibudilast was approved in Japan over 15 years ago for the treatment of bronchial asthma. Avigen elected to conduct this trial at doses above the prescribed dosage used in Asia to help guide the development of AV411 in patients with neuropathic pain. AV411 was found to be favorably tolerated in this normal volunteer study. Moreover, ibudilast single- and multi-dose pharmacokinetics were characterized, and the findings support a dosing frequency of twice daily.
BlueLinx to Announce Fourth-Quarter Results On Feb. 13
ATLANTA, Feb. 6, 2007 (PRIME NEWSWIRE) -- BlueLinx Holdings Inc. (NYSE:BXC), a leading distributor of building products in North America, announced today that it will release fourth-quarter financial results before the stock market opens on Tuesday, February 13, followed by a conference call at 10:00 a.m. EST.